Works matching IS 2396832X AND DT 2023 AND VI 8 AND IP 1
Results: 25
Efficacy of derinat as a treatment for murine and androgenetic alopecia (AGA) patients.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00159-3
- By:
- Publication type:
- Article
Exploring the clinical and genetical spectrum of ADPKD in Chile to assess ProPKD score as a risk prediction tool.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00157-5
- By:
- Publication type:
- Article
Protection of lipopolysaccharide-induced otic injury by a single dose administration of a novel dexamethasone formulation.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00156-6
- By:
- Publication type:
- Article
Antimicrobial peptide Mastoparan X has good activity against Escherichia coli in vitro and alleviates its pathogenicity in mice.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00145-9
- By:
- Publication type:
- Article
Impact of clonal hematopoiesis in COVID-19 patients at high risk for adverse clinical outcomes.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00155-7
- By:
- Publication type:
- Article
Unraveling the complexity: understanding the deconvolutions of RNA-seq data.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00154-8
- By:
- Publication type:
- Article
Translational research and key aspects to make it successful.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Mapping the knowledge structure of a gluten-free diet: a global perspective.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00152-w
- By:
- Publication type:
- Article
Meta-analysis of preclinical measures of efficacy in immune checkpoint blockade therapies and comparison to clinical efficacy estimates.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00151-x
- By:
- Publication type:
- Article
Validation of the media fill method for Cytokine-Induced killer cells manufacturing process.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00149-5
- By:
- Publication type:
- Article
Feasibility of manufacture of chimeric antigen receptor-regulatory T cells from patients with end-stage renal disease.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00150-y
- By:
- Publication type:
- Article
Adenosine, Lidocaine and Magnesium (ALM) therapy modulates early sex-specific inflammatory and immune responses following experimental anterior cruciate ligament rupture and reconstruction.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00148-6
- By:
- Publication type:
- Article
Non-invasive monitoring of pulmonary blood flow, functional residual capacity, and shunt index in a porcine model.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00146-8
- By:
- Publication type:
- Article
Circulating neutrophil extracellular trap (NET)-forming 'rogue' neutrophil subset, immunotype [DEspR + CD11b +], mediate multi-organ failure in COVID-19—an observational study.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00143-x
- By:
- Publication type:
- Article
Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford Health.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00144-w
- By:
- Publication type:
- Article
Methotrexate intolerance in Rheumatoid Arthritis.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00142-y
- By:
- Publication type:
- Article
Comparison of gene expression between human and mouse iPSC-derived cardiomyocytes for stem cell therapies of cardiovascular defects via bioinformatic analysis.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00139-7
- By:
- Publication type:
- Article
Killer cell immunoglobulin receptor diversity and its relevance in the human host's response to HIV infection in African populations.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00141-z
- By:
- Publication type:
- Article
Accessing and utilizing clinical and genomic data from an electronic health record data warehouse.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00140-0
- By:
- Publication type:
- Article
Is post-transplant day + 14 immature reticulocyte fraction (IRF) a reliable surrogate marker for predicting early platelet engraftment in pediatric hematopoietic stem cell transplant?
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00138-8
- By:
- Publication type:
- Article
A window of opportunity trial evaluating intratumoral injection of Copaxone® in patients with percutaneously accessible tumors.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00137-9
- By:
- Publication type:
- Article
Cervical catheter placement leads to improved rostral distribution of a radiolabeled 18F-baclofen analog in cynomolgus monkeys.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00136-w
- By:
- Publication type:
- Article
Expression of HIF-1α and markers of angiogenesis and metabolic adaptation in molecular subtypes of breast cancer.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-023-00135-x
- By:
- Publication type:
- Article
RLS-0071, a dual-targeting anti-inflammatory peptide - biomarker findings from a first in human clinical trial.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-022-00134-4
- By:
- Publication type:
- Article
Targeting EphA2 and DDR signaling can overcome the BRAF and MEK inhibitors acquired resistance in melanoma cell lines.
- Published in:
- Translational Medicine Communications, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41231-022-00133-5
- By:
- Publication type:
- Article